ECSP088621A - Derivados de triazoloanilinopirimidina para uso como agentes antivirales - Google Patents

Derivados de triazoloanilinopirimidina para uso como agentes antivirales

Info

Publication number
ECSP088621A
ECSP088621A EC2008008621A ECSP088621A ECSP088621A EC SP088621 A ECSP088621 A EC SP088621A EC 2008008621 A EC2008008621 A EC 2008008621A EC SP088621 A ECSP088621 A EC SP088621A EC SP088621 A ECSP088621 A EC SP088621A
Authority
EC
Ecuador
Prior art keywords
triazoloanylinopirimidine
derivatives
antiviral agents
formula
prevention
Prior art date
Application number
EC2008008621A
Other languages
English (en)
Inventor
Neil Mathews
Alexander James Floyd Thomas
Christopher John Pilkington
Keith Charles Spencer
Nathalie Tiberghien
Lyn Jennens
Surinder Chana
Ian John Fraser
Original Assignee
Arrow Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0600510A external-priority patent/GB0600510D0/en
Priority claimed from GB0612116A external-priority patent/GB0612116D0/en
Application filed by Arrow Therapeutics Ltd filed Critical Arrow Therapeutics Ltd
Publication of ECSP088621A publication Critical patent/ECSP088621A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un derivado de quinazolina de fórmula (I), o una sal farmacéuticamente aceptable del mismo: formula (I) para uso en el tratamiento de prevención de una infección por flaviviridae.
EC2008008621A 2006-01-11 2008-07-11 Derivados de triazoloanilinopirimidina para uso como agentes antivirales ECSP088621A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0600510A GB0600510D0 (en) 2006-01-11 2006-01-11 Chemical compounds
GB0612116A GB0612116D0 (en) 2006-06-19 2006-06-19 Chemical Compounds

Publications (1)

Publication Number Publication Date
ECSP088621A true ECSP088621A (es) 2008-08-29

Family

ID=37888130

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008621A ECSP088621A (es) 2006-01-11 2008-07-11 Derivados de triazoloanilinopirimidina para uso como agentes antivirales

Country Status (15)

Country Link
US (1) US20100158863A1 (es)
EP (1) EP1981876B1 (es)
JP (1) JP2009523163A (es)
KR (1) KR20080083139A (es)
AT (1) ATE508125T1 (es)
AU (1) AU2007204227B2 (es)
BR (1) BRPI0706412A2 (es)
CA (1) CA2635916A1 (es)
DE (1) DE602007014324D1 (es)
EC (1) ECSP088621A (es)
IL (1) IL191928A0 (es)
NZ (1) NZ569703A (es)
RU (1) RU2008132806A (es)
TW (1) TW200902515A (es)
WO (1) WO2007080401A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8303944B2 (en) 2006-08-11 2012-11-06 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7745636B2 (en) 2006-08-11 2010-06-29 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7659270B2 (en) 2006-08-11 2010-02-09 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7759495B2 (en) 2006-08-11 2010-07-20 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8329159B2 (en) 2006-08-11 2012-12-11 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
CA2715400A1 (en) * 2008-02-12 2009-08-20 Bristol-Myers Squibb Company Heterocyclic derivatives as hepatitis c virus inhibitors
CN102552271B (zh) 2010-12-09 2014-08-06 中国科学院上海药物研究所 一类喹唑啉类化合物在制备抗黄病毒科病毒的药物中的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT912559E (pt) * 1996-07-13 2003-03-31 Glaxo Group Ltd Compostos heterociclicos fundidos como inibidores de proteina tirosina quinase
EP1098644A1 (en) * 1998-07-20 2001-05-16 Bristol-Myers Squibb Company Substituted benzimidazole antiviral agents
WO2001087845A2 (en) * 2000-05-15 2001-11-22 Fujisawa Pharmaceutical Co., Ltd. N-containing heterocyclic compounds and their use as 5-ht antagonists
CL2004000234A1 (es) * 2003-02-12 2005-04-15 Biogen Idec Inc Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
AU2005238270A1 (en) * 2004-04-28 2005-11-10 Arrow Therapeutics Limited Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
GB0501964D0 (en) * 2005-01-31 2005-03-09 Arrow Therapeutics Ltd Chemical compounds
US8143288B2 (en) * 2005-06-06 2012-03-27 Bristol-Myers Squibb Company Inhibitors of HCV replication
GB0520475D0 (en) * 2005-10-07 2005-11-16 Arrow Therapeutics Ltd Chemical compounds

Also Published As

Publication number Publication date
EP1981876A1 (en) 2008-10-22
WO2007080401A8 (en) 2008-07-24
KR20080083139A (ko) 2008-09-16
IL191928A0 (en) 2008-12-29
RU2008132806A (ru) 2010-02-20
DE602007014324D1 (de) 2011-06-16
BRPI0706412A2 (pt) 2011-03-29
NZ569703A (en) 2011-07-29
TW200902515A (en) 2009-01-16
EP1981876B1 (en) 2011-05-04
CA2635916A1 (en) 2007-07-19
WO2007080401A1 (en) 2007-07-19
JP2009523163A (ja) 2009-06-18
US20100158863A1 (en) 2010-06-24
AU2007204227A1 (en) 2007-07-19
AU2007204227B2 (en) 2011-03-03
ATE508125T1 (de) 2011-05-15

Similar Documents

Publication Publication Date Title
ECSP088367A (es) Derivados de bifenilo y su uso en el tratamiento de la hepatitis c
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
ATE460158T1 (de) Purin-derivate als a2a-rezeptor-agonisten
ECSP099319A (es) Analogos de tiofeno para el tratamiento o prevencion de las infecciones por flavivirus
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
ECSP099436A (es) Acilaminopirazoles como inhibidores de fgfr
ATE524465T1 (de) 2-carboxy-thiophen-derivate als viruzide
TW200738725A (en) Unsaturated mTOR inhibitors
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
NO20091395L (no) Nye tiofenderivater
ECSP088621A (es) Derivados de triazoloanilinopirimidina para uso como agentes antivirales
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
MX2012006026A (es) Derivados de acido 5-alquinil-tiofen-2-carboxilico y usos para tratamiento o prevencion de infecciones por flavivirus.
ATE496918T1 (de) Als a2b-adenosinrezeptorantagonisten geeignete 5- phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4, - büpyridin-2-onderivate
CO6382176A2 (es) Derivados de urea heterociclicos y metodos de uso de los mismos-332
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
UY29859A1 (es) Derivados de 1-amino-isiquinolina,su preparación y su aplicación terapéutica
TNSN08369A1 (en) Benzimidazole derivatives
DOP2006000024A (es) Tiazolidinonas, su preparación y su uso como medicamento
CR9058A (es) Derivados de indol como inhibidores de la adenilato ciclasa soluble
CO6382113A2 (es) Compuestos quimicos
IL195837A0 (en) 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.